Inventor
Andrés Avelino Trabanco-Suárez
Inventor
Toledo, ES
Overview
Patents· 51 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,604,5231-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives202010,584,129Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors202010,537,573Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use202010,519,1626,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors201910,512,646Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors201910,112,9496,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors201810,106,542Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors201810,106,5242,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase201810,071,0951,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders201810,005,786Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of MGLUR2 receptors201810,005,785Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptors20189,845,326Substituted 3,4-dihydropyrrolo[1,2-A]pyrazines as beta-secretase (BACE) inhibitors20179,840,507'5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)'20179,828,3505,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)20179,737,533'1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders'20179,708,315'1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors'20179,346,811'6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (BACE)'20169,271,967'1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors'20169,266,834'1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors'20169,226,930'1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders'20169,181,245'Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer\'s disease'20159,174,953'Bicyclic thiazoles as allosteric modulators of mGluR5 receptors'20159,132,122'1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones'20159,114,138'1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones'20159,085,577'7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors'20159,067,891'1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors'20159,040,707'Bicyclic thiazoles as allosteric modulators of mGluR5 receptors'20159,012,448'1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors'20158,993,591'1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors'20158,946,205'1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors'20158,937,060'1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders'20158,906,939'3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives'20148,841,323'1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors'20148,796,311'3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives'20148,785,486'Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors'20148,748,621'1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones'20148,722,894'1,3-disubstituted-4-phenyl-1H-pyridin-2-ones'20148,716,480'7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors'20148,697,689'Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors'20148,691,813'Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors'20148,691,849'3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors'20148,609,660'4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (BACE)'20138,569,267'Tetracyclic tetrahydrofuran derivatives containing cyclic amine side chain'20138,546,440'Substituted bicyclic imidazole derivatives as gamma secretase modulators'20138,415,347'Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivatives'20138,404,729'Heterocyclic tetracyclic tetrahydrofuran derivatives'20138,299,101'1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators'20128,252,937'1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones'20128,022,102'Unsaturated tetracyclic tetrahydrofuran derivatives'20117,915,249'Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of CNS disorders'20117,799,785'Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivatives'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2020Patents assigned to JANSSEN PHARMACEUTICA NV (24)· patent assignee history
2010–2020Based in Olias del Rey, ES· patent location history
2011–2020Based in Toledo, ES· patent location history
2012–2018Patents assigned to JANSSEN PHARMACEUTICALS INC (26)· patent assignee history
2012–2015Patents assigned to TRABANCO-SUAREZ ANDRES AVELINO (20)· patent assignee history
2012–2015Patents assigned to CID-NUNEZ JOSE MARIA (18)· patent assignee history
2012–2016Patents assigned to MACDONALD GREGOR JAMES (18)· patent assignee history
2012–2015Based in Olias del Ray, ES· patent location history
2015Based in Toldeo, ES· patent location history
2016Based in Madrid, ES· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICALS INC | 26 | 2012–2018 |
| JANSSEN PHARMACEUTICA NV | 24 | 2010–2020 |
| TRABANCO-SUAREZ ANDRES AVELINOself | 20 | 2012–2015 |
| CID-NUNEZ JOSE MARIA | 18 | 2012–2015 |
| MACDONALD GREGOR JAMES | 18 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Toledo, ES | 35 | 2011–2020 |
| Olias del Rey, ES | 10 | 2010–2020 |
| Olias del Ray, ES | 4 | 2012–2015 |
| Madrid, ES | 1 | 2016 |
| Toldeo, ES | 1 | 2015 |